Crinetics Pharmaceuticals, Inc. (CRNX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Crinetics Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -9.41x | -13.84x | -9.63x | -5.80x | -10.14x | -5.82x |
| P/B Ratio | 4.41x | 3.12x | 3.83x | 3.01x | 3.29x | 2.54x |
| P/S Ratio | 568.91x | 3975.39x | 514.87x | 200.82x | 1012.96x | 6051.00x |
| Profitability | ||||||
| Gross Margin | 86.0% | 100.0% | 100.0% | 100.0% | 100.0% | -80178.9% |
| Operating Margin | -6714.8% | -32613.5% | -5547.2% | -3544.1% | -9990.9% | -105567.6% |
| Net Margin | -6046.2% | -28720.7% | -5345.9% | -3460.4% | -9985.3% | -103960.6% |
| EBITDA Margin | -6664.2% | -32345.4% | -5519.8% | -3523.3% | -9905.4% | -104232.4% |
| Liquidity | ||||||
| Current Ratio | 12.32x | 23.04x | 13.07x | 12.45x | 21.55x | 16.92x |
| Quick Ratio | 12.30x | 23.04x | 13.07x | 12.45x | 21.55x | 16.92x |
| Leverage | ||||||
| Debt/Equity | 0.05x | 0.04x | 0.10x | 0.01x | 0.01x | 0.02x |
YoY = year-over-year change. Source: FMP..